TrakCel Ltd. Adds Cognate BioSevices to Connected Services Program

Published on: 

Connected Services program will link cGMP-manufacturing services with supply chain technology management solution.

TrakCel Ltd., a cell therapy process management and supply chain integration technology, recently introduced Cognate BioServices as the newest member of its Connected Service program, according to a Nov. 10, 2015 press release. 

Cognate Bioservices is a fully integrated contract bioservices organization providing development and cGMP-manufacturing services to institutions engaged in the development of cell-based products.

The Connected Services partner ecosystem accelerates cell therapy success by enhancing TrakCel's cell therapy supply chain management platform, according to TrakCel. This improvement to the platform supports therapy success by providing links to participant firms specializing in logistics, cell therapy manufacturing, patient treatment, storage, and compliance.


TrakCel’s technology provides additional transparency into the entire cell therapy process, while providing real-time audit logs and chain-of-custody records of critical components.

Source: TrakCel